NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis
Open Access
- 15 October 2013
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 123 (11), 4731-4738
- https://doi.org/10.1172/jci67603
Abstract
ROS are implicated in bone diseases. NADPH oxidase 4 (NOX4), a constitutively active enzymatic source of ROS, may contribute to the development of such disorders. Therefore, we studied the role of NOX4 in bone homeostasis. Nox4–/– mice displayed higher bone density and reduced numbers and markers of osteoclasts. Ex vivo, differentiation of monocytes into osteoclasts with RANKL and M-CSF induced Nox4 expression. Loss of NOX4 activity attenuated osteoclastogenesis, which was accompanied by impaired activation of RANKL-induced NFATc1 and c-JUN. In an in vivo model of murine ovariectomy–induced osteoporosis, pharmacological inhibition or acute genetic knockdown of Nox4 mitigated loss of trabecular bone. Human bone obtained from patients with increased osteoclast activity exhibited increased NOX4 expression. Moreover, a SNP of NOX4 was associated with elevated circulating markers of bone turnover and reduced bone density in women. Thus, NOX4 is involved in bone loss and represents a potential therapeutic target for the treatment of osteoporosis.Keywords
This publication has 40 references indexed in Scilit:
- Steroids and osteoporosis: the quest for mechanismsJCI Insight, 2013
- Expression of Nox4 in osteoclastsJournal of Cellular Biochemistry, 2004
- Involvement of Calcineurin in Transforming Growth Factor-β-mediated Regulation of Extracellular Matrix AccumulationPublished by Elsevier BV ,2004
- Genetic Predisposition for Adult Lactose Intolerance and Relation to Diet, Bone Density, and Bone FracturesJournal of Bone and Mineral Research, 2004
- Involvement of capacitive calcium entry and calcium store refilling in osteoclastic survival and bone resorption processCell Calcium, 2003
- Macrophage colony-stimulating factor promotes the survival of osteoclast precursors by up-regulating Bcl-XLExperimental & Molecular Medicine, 2002
- Regulation of osteoclastogenesis and RANK expression by TGF‐β1Journal of Cellular Biochemistry, 2001
- Osteoprotegerin Ligand Modulates Murine Osteoclast Survival in Vitro and in VivoThe American Journal of Pathology, 2000
- Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ERT and Cre-ERT2 recombinasesNucleic Acids Research, 1999
- Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo.JCI Insight, 1990